CAR-T

reshuffle pipeline target reorganize shift change
Biotech

Sana, CAMP4 ditch clinical-stage assets for preclinical hopefuls

Sana, CAMP4 and Crinetics have used the third quarter to refocus their pipelines on the most promising candidates.
James Waldron Nov 7, 2025 8:13am
Metallic arrow symbols illuminated by blue and magenta lights forming a graph on blue and magenta background

Kyverna links CAR-T to autoimmune improvements in small trial

Oct 29, 2025 10:00am
Make a delay and accumulation of outstanding tasks Full stop

Regeneron does 180 on 2seventy lymphoma CAR-T

Oct 23, 2025 10:57am
kite

Kite puts $1.64B on the line for Pregene's in vivo CAR-Ts

Oct 16, 2025 4:56pm
transparent open honest clean wipe squeegee clear

Cabaletta's CAR-T wipes out B cells with no preconditioning

Oct 10, 2025 11:11am
circle

BMS inks $1.5B deal to pull Orbital into its sphere of influence

Oct 10, 2025 8:45am